Migration and proliferation of human mesenchymai stem cells from patients with systemic lupus erythematosus mediated by IKK-β

Ji-yun ZHANG,Lei LIU,De-fang MENG,Yu TANG,Dong-yan SHI,Dan-dan WANG,Hui-qing LIU,Xia LI,Ling-yun SUN
DOI: https://doi.org/10.3760/cma.j.issn.1007-7480.2011.11.010
2011-01-01
Abstract:Objective To investigate the effect of IκB kinase (IKK-β) on migration and proliferation of bone marrow mesenchymal stem cells (BMSCs) from patients with systemic lupus erythematosus (SLE).Methods Human bone marrow aspirates were collected from iliac of six donors and six SLE patients and cultured in vitro.Migration of BMSCs were observed by wound healing and transwell migration assays.Proliferation of BMSCs was quantified by cell counting kit-8 assay.Total RNA was extracted and reverse transcribed into complementary DNA.Real-time PCR technique was used to determine the gene expression of IKK-β at transcription level.The expression of IKK-β and phospho-IKK-β (p-IKK-β) protein were determined by Western blotting analysis.Statistical analysis was conducted with or Mann-Whitney rank test.Results ① The migration rate of BMSCs from SLE patients (5.2±3.8)‰ were significantly reduced as compared with normal controls (7.0±2.9)‰(P<0.05 ).The proliferation of BMSCs of SLE patients (0.21±0.49)was lower than that from healthy controls ( 1.00±0.35 )(P<0.05 ).②) No difference in IKK-β3 mRNA expression between SLE ( 1.9± 1.4) subjects and normal controls (1.9±2.4) (P>0.05).IKK-β protein expression of BMSCs from SLE patients (1.41 ±0.19) increased significantly compared with healthy controls (0.93±1.24) (P<0.05).③ Inhibitor of IKK-β caused a significant increase in cell migration (3.3±1.6)‰ and proliferation (1.13±0.26) of BMSCs from SLE patients compared with untreated cells (2.3±1.1)‰ and (0.81±0.17),respectively (P<0.05).Conclusion Migration and proliferation of BMSCs are significantly decreased in SLE patients.IKK-β may be involved in migration and proliferation of BMSCs.
What problem does this paper attempt to address?